Randomized phase III study comparing a non-myeloablative lymphocyte depleting regimen of chemotherapy followed by infusion of tumor infiltrating lymphocytes and interleukine-2 to standard ipilimumab treatment in metastatic melanoma - Rohaan, M W; Borch, T H; van den Berg, J H (Ann Oncol, 2018)
et al.